Scilex Holding (NASDAQ:SCLXW – Get Free Report) rose 15.8% during trading on Friday . The company traded as high as $0.12 and last traded at $0.11. Approximately 652 shares were traded during mid-day trading, a decline of 91% from the average daily volume of 7,388 shares. The stock had previously closed at $0.10.
Scilex Stock Up 15.8 %
The business has a fifty day simple moving average of $0.16 and a 200 day simple moving average of $0.23.
About Scilex
Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical system) 1.8% (ZTlido), a prescription lidocaine topical product for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a ready-to-use oral solution for the acute treatment of migraine with or without aura in adults; and GLOPERBA, a liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.
Featured Stories
- Five stocks we like better than Scilex
- How to Start Investing in Real Estate
- AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- 3 ETFs to Ride the VIX Surge During Market Volatility
- EV Stocks and How to Profit from Them
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
Receive News & Ratings for Scilex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scilex and related companies with MarketBeat.com's FREE daily email newsletter.
